15/01/2016
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
The Parc Tecnològic del Vallès (PTV) is the oldest technology park in Spain (1987). PTV can be considered as the initial phase of a more global project of a territory designed to attract innovative companies in the environment of the Universitat Autònoma de Barcelona. This project has matured with the second phase corresponding to the creation of the Barcelona Synchrotron Park (BSP) around the ALBA synchrotron operative since 2012.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
More news
03/01/2020
AllRead MLT, a success story originated from the PRUAB’s Ideas Generation Program
06/11/2019
SENER, a top-class aerospace systems provider
29/10/2019
The ICN2 research center is involved in the quantum revolution
21/10/2019
Stradivarius keeps growing
19/09/2019
The president of Catalonia visited the Barcelona Synchrotron Park
12/09/2019
Alba, a tool to tackle challenges in the fields of renewable energy production and fight against air pollution
home